about
Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus studySodium/hydrogen exchanger NHA2 in osteoclasts: subcellular localization and role in vitro and in vivoCommon variants in CLDN14 are associated with differential excretion of magnesium over calcium in urine.Local renal circadian clocks control fluid-electrolyte homeostasis and BPFunctional expression of a pseudohypoaldosteronism type I mutated epithelial Na+ channel lacking the pore-forming region of its alpha subunit.Dysfunction of epithelial sodium transport: from human to mouse.Two new families with hereditary minimal change disease.Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrationsAssociation of urinary calcium excretion with serum calcium and vitamin D levels.Forms of mineralocorticoid hypertension.Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system.Sodium-dependent phosphate transporters in osteoclast differentiation and function.Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression.Variability in urinary oxalate measurements between six international laboratories.The circadian clock modulates renal sodium handling.Genetic hypercalciuria.Increased bone resorption by osteoclast-specific deletion of the sodium/calcium exchanger isoform 1 (NCX1).Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system.Mechanism of urinary calcium regulation by urinary magnesium and pH.A novel LAMB2 gene mutation associated with a severe phenotype in a neonate with Pierson syndromeCircadian regulation of renal function.A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule.Calcium, vitamin D and cardiovascular disease.Role of the renal circadian timing system in maintaining water and electrolytes homeostasis.Molecular bases of circadian rhythmicity in renal physiology and pathology.Circadian glomerular function: from physiology to molecular and therapeutical aspects.Ways of calcium reabsorption in the kidney.Mutations in the polyglutamylase gene TTLL5, expressed in photoreceptor cells and spermatozoa, are associated with cone-rod degeneration and reduced male fertility.FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron.Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug DispositionA novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.[Weil's disease: a case report of acquired leptospirosis in Switzerland].Loss of Memo, a novel FGFR regulator, results in reduced lifespan.Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.[Diagnosis and prevention of uric acid stones]Mouse GLUT9: evidences for a urate uniporter.PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation.Circadian variation of ticagrelor-induced platelet inhibition in healthy adulty.
P50
Q28740864-F80D263D-C33A-4ACB-8F09-99BBF6ABFA60Q28910193-82CFC0FC-23DE-4DEC-B093-C8220C6E3426Q30240207-3CF7DEF2-FA12-4D97-B9C1-3F0EF217A01EQ30384431-F24D72F4-F397-41DD-A239-E9F16BF9553CQ33858466-A0094070-616D-4BF9-ADFE-E9E7767DA51BQ33888866-17BD5AA5-FECB-41F6-B34D-60D490D2DFC6Q34630984-58412A8F-1BF5-406A-9B7F-C29F35C38B17Q34998326-4CF39754-F51E-4682-811D-9FF378C18FF5Q35144471-A02221EE-B72A-46B2-8037-ADDA5F3B3227Q35173855-F37E72C9-5187-40D5-9B34-25779C97D757Q35305493-22589413-323A-4B76-9FD2-26607CB4FA58Q35536195-63240D40-1E0A-4A4F-90FB-D8D107D199E5Q35559202-68701CDC-7FBF-4DB4-AA4D-7E61DA065448Q35661937-A013DB6A-B17E-4143-B3A3-185E5A2D1311Q35982363-38E94021-2AC4-4EA2-9121-2320C273CA80Q36028967-B17A9BB1-7647-463D-8F31-E38D24AEBE7AQ36220413-79A2F2FE-F648-4151-A6AA-DED9287074FBQ36275483-C1AE64F2-73B9-4A46-9E13-E7D7E25DE287Q36796790-B64398BE-DA60-41D6-8913-4EF8601E76D2Q36853729-31E7FBDF-DBD1-40AE-964D-E444C243A329Q37776149-C0718E5A-3995-4B78-80B2-2801659DFC75Q37777967-6ABA1F5B-98B4-4DE5-95E0-8C32D26AC87FQ37890202-D50D0FAE-B4BC-468C-AB00-6D8F70093866Q37901810-C59FC434-D223-40D5-B986-BE571CF8BFAFQ38125436-9CA7D0E1-DB6D-463C-8B97-2861E377B183Q38187106-D0E17997-5020-417F-A260-5F296576BCEDQ38786641-580897D7-1FDE-43B3-B764-EACF509C750DQ38973831-AD2026EE-73DF-4F3F-8D9C-0DDABB567F57Q39496020-ABEE91C4-CE39-42D7-ABD0-510EA6BCD6D1Q40472986-B8B96FFC-E796-4E7A-935E-8016FA85ACDBQ41645452-36C01AD0-2E89-4DCE-8D44-B6FA5D82EF32Q44177359-F1BAC814-8352-46C2-AFFC-D6AC729D5029Q44209612-68D51576-6D9A-4906-A765-E3E30B57C00BQ44357499-FAC5EA5F-6CDB-4B1B-A1AE-9E185E13D9B8Q45020373-4DCCD349-2CA0-4077-BE10-0F8AC79DD061Q45113926-470AB142-74A0-40F1-9F15-CCADDEB898BDQ45935171-168E23ED-4D9C-4307-86E3-CDA8E10DC33AQ46656803-32343B29-9ABE-4CDB-9A10-A5C4D99CBAA1Q46752665-CA234267-2F04-4C88-8346-AF6D49224D13Q47549080-9ED9B90C-EE0C-4FFA-BB3B-FBC3EA38CCCC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Olivier Bonny
@ast
Olivier Bonny
@en
Olivier Bonny
@es
Olivier Bonny
@nl
type
label
Olivier Bonny
@ast
Olivier Bonny
@en
Olivier Bonny
@es
Olivier Bonny
@nl
prefLabel
Olivier Bonny
@ast
Olivier Bonny
@en
Olivier Bonny
@es
Olivier Bonny
@nl
P106
P31
P496
0000-0003-4123-4279